Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd.AS OF 07 MAR 2024 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
00:10:00
Rabobank's Robust Financial Results and Sustainability Initiatives | Wiebe Draijer, CEO, Rabobank.
00:10:00
Black Iron Inc: Leading Ukraine's High-Grade Iron Ore Project
00:10:00
Helps the daring build legendary companies from idea to IPO and beyond|Bogomil Balkansky,Partner,Sequoia Capital
00:10:00
Platinum Group Metals CEO Discusses Palladium Project Development and Market Potential
00:10:00
Biotech Analysts Unveil AI's Impact: Revolutionizing Drug Discovery for a Promising 2024|JEFFREY M. SOLOMON,President, TD Cowen
00:10:00
3U HOLDING AG - Annual review 2019 | Christoph Hellrung, CFO, 3U Holding AGUUUX:GER
00:10:00
Friend or Finance? Navigating Money Requests | MYRA SALZER - CFP of The Wealth Conservancy, Inc.
00:10:00
Antony Beckmand Explores Ertelien’s Historic Drilling Program in Latest Kuniko Interview | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Athanasios Papanikolaou and Vivartia's Agri-Food Leadership Part-2 | Athanasios Papanikolaou, CEO, Marfin Investment Group.
00:10:00
EDP CEO Miguel Stilwell d'Andrade on the Role of Utilities in the Low-Carbon Transition
00:10:00
Committed to building the ecosystem of capital|Elana Berkowitz,Founding Partner,Springbank Collective

© 2026 Nehu